Stocksigma LogoStocksigma Logo

Divis Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

■ Revenue: 3,676 (+35.4% YoY | +19.4% QoQ) ■ EBITDA: 1,566 (+76.4% YoY | +24.8% QoQ) ■ EBITDA Margin (%): 42.6 (+989 bps YoY | +185 bps QoQ) ■ PAT: 1,127

Divis Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

Divis Laboratories Ltd · Outcome · 07 Nov 2026, 5:26 pm

Divis Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 3,676 (+35.4% YoY | +19.4% QoQ) ■ EBITDA: 1,566 (+76.4% YoY | +24.8% QoQ) ■ EBITDA Margin (%): 42.6 (+989 bps YoY | +185 bps QoQ) ■ PAT: 1,127 (+63.6% YoY | +24.9% QoQ) ■ EPS (INR): 42.5 (+63.6% YoY | +25.2% QoQ)

Original exchange filing (PDF)

More announcements from Divis Laboratories Ltd

All Divis Laboratories Ltd announcements